SMUP-IA-01(mid-dose)

BIOLOGICAL3 trials

Sponsors

Medipost Co Ltd.

Conditions

Knee Osteoarthritis

Phase 1

Evaluate Safety and Explore Efficacy of SMUP-IA-01 in Patients With Knee Osteoarthritis

CompletedNCT04037345

Medipost Co Ltd.Knee Osteoarthritis

Start: 2019-10-07End: 2020-11-12Updated: 2021-02-24

Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial

Medipost Co Ltd.Knee Osteoarthritis

Start: 2020-04-14End: 2025-12-31Target: 12Updated: 2023-03-15

Phase 2

Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control

Active, not recruitingNCT06798727

Medipost Co Ltd.Knee Osteoarthritis

Start: 2023-03-20End: 2027-11-30Updated: 2025-02-07